OR7A17 Inhibitors
OR7A17 inhibitors are conceptual chemical compounds designed to selectively interact with the olfactory receptor 7A17 (OR7A17), a member of the G protein-coupled receptor (GPCR) family involved in the detection of odorant molecules. These inhibitors would function by binding to specific sites on the OR7A17 receptor, potentially modulating its ability to interact with natural ligands and altering the signal transduction pathways associated with olfactory perception. By targeting OR7A17, such compounds could provide researchers with valuable tools to study the receptor's specific role in the complex processes of smell perception and neural signaling within the olfactory system.
The design and development of OR7A17 inhibitors involve advanced techniques in computational chemistry, molecular modeling, and organic synthesis. Researchers might employ methods like molecular docking and structure-activity relationship studies to predict how potential inhibitory compounds could interact with the receptor at the molecular level. The chemical structures of these inhibitors would be crafted to mimic or block the natural ligands of OR7A17, aiming for high specificity and affinity. Investigating these inhibitors contributes to a deeper understanding of olfactory receptor function and aids in elucidating the broader neural networks involved in sensory perception. This research enhances our knowledge of the molecular mechanisms underlying the sense of smell and supports the advancement of neurobiological studies related to sensory systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This cytidine analog could cause hypomethylation of the OR7A17 promoter, potentially leading to the suppression of its transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an inhibitor of histone deacetylases, Trichostatin A could tighten chromatin structure around the OR7A17 locus, resulting in decreased transcriptional activity. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
This compound could bind to G-C rich sequences in the OR7A17 promoter, obstructing the binding of transcription factors necessary for OR7A17 gene transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could inhibit the mTOR pathway, potentially leading to reduced transcriptional activity of genes like OR7A17 that may be indirectly controlled by this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This MEK inhibitor could decrease the ERK pathway activity, leading to reduced expression of OR7A17 if it is dependent on ERK signaling for transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 could inhibit PI3K, which may lead to a downstream reduction in transcription factors that drive OR7A17 expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound intercalates into DNA and could directly inhibit the transcription initiation complex formation at the OR7A17 gene, leading to decreased mRNA synthesis. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin could specifically inhibit RNA polymerase II, leading to a direct decrease in the transcription of the OR7A17 mRNA. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
By inhibiting the Wnt/β-catenin pathway, Wnt-C59 could downregulate the transcription of OR7A17, assuming that this signaling pathway positively controls its gene expression. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT could inhibit γ-secretase, leading to a decrease in Notch receptor signaling; if OR7A17 expression is linked to Notch pathway activity, this could result in decreased OR7A17 expression. | ||||||